[go: up one dir, main page]

DE60140936D1 - Glycosylierte hybrid-verbindungen, deren herstellung und verwendung - Google Patents

Glycosylierte hybrid-verbindungen, deren herstellung und verwendung

Info

Publication number
DE60140936D1
DE60140936D1 DE60140936T DE60140936T DE60140936D1 DE 60140936 D1 DE60140936 D1 DE 60140936D1 DE 60140936 T DE60140936 T DE 60140936T DE 60140936 T DE60140936 T DE 60140936T DE 60140936 D1 DE60140936 D1 DE 60140936D1
Authority
DE
Germany
Prior art keywords
polyketides
polyketide
glycosylated
ability
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140936T
Other languages
English (en)
Inventor
Peter Francis Leadlay
James Staunton
Sabine Gaisser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotica Technology Ltd
Original Assignee
Biotica Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0009207.2A external-priority patent/GB0009207D0/en
Application filed by Biotica Technology Ltd filed Critical Biotica Technology Ltd
Application granted granted Critical
Publication of DE60140936D1 publication Critical patent/DE60140936D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60140936T 2000-04-13 2001-04-17 Glycosylierte hybrid-verbindungen, deren herstellung und verwendung Expired - Lifetime DE60140936D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0009207.2A GB0009207D0 (en) 2000-04-13 2000-04-13 Hybrid glycosylated products and their production and use
US69421800A 2000-10-23 2000-10-23
PCT/GB2001/001743 WO2001079520A1 (en) 2000-04-13 2001-04-17 Hybrid glycosylated products and their production and use

Publications (1)

Publication Number Publication Date
DE60140936D1 true DE60140936D1 (de) 2010-02-11

Family

ID=26244108

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140936T Expired - Lifetime DE60140936D1 (de) 2000-04-13 2001-04-17 Glycosylierte hybrid-verbindungen, deren herstellung und verwendung

Country Status (10)

Country Link
US (1) US7482137B2 (de)
EP (1) EP1278881B1 (de)
JP (1) JP5037771B2 (de)
AT (1) ATE453719T1 (de)
AU (2) AU2001248588B2 (de)
CA (1) CA2405958C (de)
DE (1) DE60140936D1 (de)
DK (1) DK1278881T3 (de)
ES (1) ES2338212T3 (de)
WO (1) WO2001079520A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128680D0 (en) * 2001-11-29 2002-01-23 Biotica Tech Ltd Hybrid glycosylated products and their production and use
WO2004007709A2 (en) 2002-07-16 2004-01-22 Biotica Technology Limited Production of polyketides
EP2388333A3 (de) 2003-06-19 2012-04-04 Evolva SA Verfahren zur Herstellung einer organischen Verbindung mit geringem Molekulargewicht in einer Zelle
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
GB0327721D0 (en) * 2003-11-28 2003-12-31 Biotica Tech Ltd Polyketides and their synthesis
WO2006003456A2 (en) * 2004-07-07 2006-01-12 Isis Innovation Limited Glycosylation of antibiotics
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
JP5196856B2 (ja) * 2007-05-14 2013-05-15 キヤノン株式会社 プローブセット、プローブ担体及び検査方法
WO2010034243A1 (en) 2008-09-24 2010-04-01 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Novel gene cluster
CN103849591B (zh) * 2012-12-05 2017-07-07 中国科学院上海有机化学研究所 一种泰乐菌素产生菌、遗传改造方法及其应用
CN103215282B (zh) * 2013-04-09 2016-08-03 中国科学院上海有机化学研究所 越野他汀的生物合成基因簇及其应用
CN107075461B (zh) 2014-11-14 2020-10-23 浙江海正药业股份有限公司 多杀菌素异源表达菌株及其构建方法和应用
WO2018153954A1 (en) 2017-02-22 2018-08-30 Immune System Regulation Holding Ab Novel immune stimulating macrolide
EP3585796B1 (de) 2017-02-22 2021-06-16 ISR Immune System Regulation Holding AB (publ) Neuartige immun-stimulierende macrolide
CN110678476A (zh) 2017-02-22 2020-01-10 免疫系统调节控股有限公司 新型免疫刺激大环内酯
US11059846B2 (en) 2017-02-22 2021-07-13 ISR Immune System Regulation Holding AB (publ) Immune stimulating compound
CN107226830B (zh) * 2017-05-02 2019-12-10 北京理工大学 一种乙基多杀菌素的化学合成方法
AU2019237257A1 (en) 2018-03-23 2020-10-15 ISR Immune System Regulation Holding AB (publ) Combinations of macrolide compounds and immune checkpoint inhibitors
KR102705165B1 (ko) 2019-01-22 2024-09-11 에오비안 파마슈티컬스, 인크. Mtorc 조절제 및 이의 용도

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598805A (en) 1970-02-26 1971-08-10 Abbott Lab Erythromycin ester derivatives
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
DE3268339D1 (en) * 1981-01-09 1986-02-20 Pierrel Spa Novel semisynthetic macrolidic antibiotics, microbiological processes for their preparation and related microorganism, novel intermediate compounds for their preparation and related pharmaceutical compositions containing them
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
SE9201544L (sv) * 1991-05-31 1992-12-01 Ciba Geigy Ag Saett att framstaella glykosyltransferaser
GB2256197B (en) * 1991-05-31 1995-11-22 Ciba Geigy Ag Yeast as host for expression of heterologous glycosyl transferase enzymes
JPH07503363A (ja) * 1991-11-14 1995-04-13 ノボザイムス アクティーゼルスカブ バシラス・リヘニフォルミス中で遺伝子を発現させる方法
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
ES2164713T3 (es) 1993-09-20 2002-03-01 Univ Leland Stanford Junior Produccion recombinante de nuevos poliquetidos.
US5834251A (en) 1994-12-30 1998-11-10 Alko Group Ltd. Methods of modifying carbohydrate moieties
US5998194A (en) 1995-12-21 1999-12-07 Abbott Laboratories Polyketide-associated sugar biosynthesis genes
WO1998001571A2 (en) 1996-07-05 1998-01-15 Biotica Technology Limited Erythromycins and process for their preparation
US5871983A (en) 1996-09-13 1999-02-16 Eli Lilly And Company Glucosyltransferase gene GTFE from amycolatopsis orientalis
AU732909B2 (en) * 1997-04-30 2001-05-03 Board Of Trustees Of The Leland Stanford Junior University Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
WO1999005283A2 (fr) 1997-07-25 1999-02-04 Hoechst Marion Roussel Genes de biosynthese et de transfert des 6-desoxyhexoses chez saccharopolyspora erythraea et chez streptomyces antibioticus et leur utilisation
AR043071A1 (es) 1997-10-31 2005-07-20 Abbott Lab Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
GB9814006D0 (en) 1998-06-29 1998-08-26 Biotica Tech Ltd Polyketides and their synthesis
EP1095058A4 (de) 1998-07-14 2003-07-16 Univ Princeton Glykopeptidantibiotika, kombinatorische bibliotheken von glykopeptidantibiotika und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
WO2001079520A1 (en) 2001-10-25
ATE453719T1 (de) 2010-01-15
EP1278881A1 (de) 2003-01-29
AU4858801A (en) 2001-10-30
CA2405958A1 (en) 2001-10-25
US7482137B2 (en) 2009-01-27
ES2338212T3 (es) 2010-05-05
EP1278881B1 (de) 2009-12-30
DK1278881T3 (da) 2010-05-10
CA2405958C (en) 2011-08-09
AU2001248588B2 (en) 2006-02-02
JP5037771B2 (ja) 2012-10-03
US20070092944A1 (en) 2007-04-26
JP2003530857A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
DE60140936D1 (de) Glycosylierte hybrid-verbindungen, deren herstellung und verwendung
Kim et al. Biosynthesis and production of glycosylated flavonoids in Escherichia coli: current state and perspectives
Fan et al. Amino acid and glucose metabolism in fed‐batch CHO cell culture affects antibody production and glycosylation
Taniguchi et al. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics
Wong et al. Specificity, inhibition, and synthetic utility of a recombinant human. alpha.-1, 3-fucosyltransferase
Yang et al. Natural product glycorandomization
Xu et al. A novel enzymatic method for synthesis of glycopeptides carrying natural eukaryotic N-glycans
Peacock et al. Amino acid–dependent stability of the acyl linkage in aminoacyl-tRNA
Yang et al. A glycosynthase catalyst for the synthesis of flavonoid glycosides
MXPA05009353A (es) Composiciones de grano que contienen isomalto-oligosacaridos pre-bioticos y metodos para la elaboracion y uso de las mismas.
ES2266159T3 (es) Mejora de la galactosilacion de glicoproteinas recombinantes.
EP1581617B8 (de) Verfahren zur herstellung von endprodukten aus kohlenstoffsubstraten
JP2013533736A5 (de)
ES2046323T3 (es) Un procedimiento de preparacion enzimatica de oligodextranos utiles en la fabricacion de substitutos del azucar, asi como nuevos oligodextranos.
DE69535543D1 (de) Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
EP1576160B8 (de) Borrelidin-derivate und ihre medizinische anwendung
Zhang et al. Combined effects of glycosylation precursors and lactate on the glycoprofile of IgG produced by CHO cells
EP3330374B1 (de) Glycosyltransferase-glycosylierende flavokermessäure und/oder kermessäure
BRPI0514213A (pt) maior redução da zeìna na semente de milho transgênica
Hossler et al. Cell culture media supplementation of infrequently used sugars for the targeted shifting of protein glycosylation profiles
Rohfritsch et al. Probing the substrate specificity of four different sialyltransferases using synthetic β-d-Galp-(1→ 4)-β-d-GlcpNAc-(1→ 2)-α-d-Manp-(1→ O)(CH2) 7CH3 analogues: General activating effect of replacing N-acetylglucosamine by N-propionylglucosamine
Luley-Goedl et al. Two N-terminally truncated variants of human β-galactoside α2, 6 sialyltransferase I with distinct properties for in vitro protein glycosylation
WO2002079150A3 (en) Glycorandomization and the production of novel erythronolide and coumarin analogs
Unverzagt et al. Chemoenzymatic synthesis of deca and dodecasaccharide N-glycans of the ‘bisecting’type
AU2002344055A1 (en) Process for producing alpha2,3/alpha2,8-sialyltransferase and sialic acid-containing complex sugar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition